Ellen Brady
@elleneebee.bsky.social
Reposted by Ellen Brady
I could stare at this view of the sun all day (and luckily, it won't burn my corneas). That and more of the best from @science.org and science in this edition of #ScienceAdviser: www.science.org/content/arti... 🧪 ☀
May 30, 2025 at 6:29 PM
I could stare at this view of the sun all day (and luckily, it won't burn my corneas). That and more of the best from @science.org and science in this edition of #ScienceAdviser: www.science.org/content/arti... 🧪 ☀
Reposted by Ellen Brady
In general, depression scores tend to reduce over time. Indeed, this study found precisely that! And yet, they still reported these useless results and got published, and have been included in dozens of systematic reviews since.
Wild.
Wild.
June 2, 2025 at 12:31 AM
In general, depression scores tend to reduce over time. Indeed, this study found precisely that! And yet, they still reported these useless results and got published, and have been included in dozens of systematic reviews since.
Wild.
Wild.
Reposted by Ellen Brady
Sometimes I just despair about published trials.
This RCT, cited 90 times as per Scholar, reported massive benefits for psychodynamic psychotherapy.
The only problem? Outcomes assessment was conducted a FULL 20 WEEKS LATER IN THE TREATMENT GROUP THAN THE CONTROL.
This RCT, cited 90 times as per Scholar, reported massive benefits for psychodynamic psychotherapy.
The only problem? Outcomes assessment was conducted a FULL 20 WEEKS LATER IN THE TREATMENT GROUP THAN THE CONTROL.
June 2, 2025 at 12:31 AM
Sometimes I just despair about published trials.
This RCT, cited 90 times as per Scholar, reported massive benefits for psychodynamic psychotherapy.
The only problem? Outcomes assessment was conducted a FULL 20 WEEKS LATER IN THE TREATMENT GROUP THAN THE CONTROL.
This RCT, cited 90 times as per Scholar, reported massive benefits for psychodynamic psychotherapy.
The only problem? Outcomes assessment was conducted a FULL 20 WEEKS LATER IN THE TREATMENT GROUP THAN THE CONTROL.